Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
The cysteine protease of group A streptococci has been suggested to contribute to the pathogenesis of invasive infection through degradation of host tissue, activation of the host inflammatory response, release of protective molecules from the bacterial cell surface, or other mechanisms. However, studies of the effects on virulence of inactivating the cysteine protease gene speB have yielded conflicting results. In some reports, a speB mutant was relatively avirulent in mouse models of invasive infection whereas little or no attenuation of virulence was observed in other studies of similar mutant strains. Possible reasons for these discordant results include differences in the streptococcal strains from which the speB mutants were derived, differences in the infection models employed, or unintended effects on another virulence determinant(s) that arose during the derivation of a speB mutant. We attempted to clarify these issues by characterizing the phenotypic properties and relative virulence in mice of two speB mutant strains, both derived from wild-type strain AM3: speB mutant AM3speB, which has been shown to be markedly attenuated in virulence in mice after intraperitoneal or subcutaneous challenge, and AM3speBOmega, a new mutant strain derived for this investigation. Both mutant strains were negative for protease activity, as expected, and both produced wild-type amounts of type 3 M protein and streptolysin O. However, AM3speB produced significantly less cell-associated hyaluronic acid capsule than did parent strain AM3 or strain AM3speBOmega. Compared to wild-type strain AM3, AM3speB was more sensitive to opsonophagocytic killing in vitro and was significantly less virulent in mice after intraperitoneal challenge. By contrast, AM3speBOmega was fully resistant to phagocytosis and did not differ significantly from the wild-type strain in mouse virulence after an intraperitoneal or subcutaneous challenge. We concluded that previous reports attributing loss of virulence in strain AM3speB to inactivation of speB are in error. Within the limitations of the models used, we found no effect of cysteine protease on invasive streptococcal infection.
Ashbaugh
C D
CD
Channing Laboratory and Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. cashbaugh@channing.harvard.edu
Wessels
M R
MR
D000818:Animals; D001426:Bacterial Proteins; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000502:physiology*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D051379:Mice; D008813:Mice, Inbred ICR; D010587:Phagocytosis / Q000276:immunology; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000201:enzymology* / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity; D014774:Virulence
D001426:Bacterial Proteins; D003546:Cysteine Endopeptidases; C042477:streptopain